UFLEX - Uflex Limited Share Price
Industrial Products
Valuation | |
|---|---|
| Market Cap | 3.9 kCr |
| Price/Earnings (Trailing) | 13.06 |
| Price/Sales (Trailing) | 0.25 |
| EV/EBITDA | 5.86 |
| Price/Free Cashflow | -6.54 |
| MarketCap/EBT | 9.36 |
| Enterprise Value | 10.89 kCr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 15.42 kCr |
| Rev. Growth (Yr) | 6.5% |
| Earnings (TTM) | 298.79 Cr |
| Earnings Growth (Yr) | 158.9% |
Profitability | |
|---|---|
| Operating Margin | 3% |
| EBT Margin | 3% |
| Return on Equity | 4.04% |
| Return on Assets | 1.54% |
| Free Cashflow Yield | -15.29% |
Price to Sales Ratio
Revenue (Last 12 mths)
Net Income (Last 12 mths)
Growth & Returns | |
|---|---|
| Price Change 1W | -1.8% |
| Price Change 1M | 4.6% |
| Price Change 6M | 5.8% |
| Price Change 1Y | -20.6% |
| 3Y Cumulative Return | -9.5% |
| 5Y Cumulative Return | 11.5% |
| 7Y Cumulative Return | 9% |
| 10Y Cumulative Return | 13.2% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | -1.73 kCr |
| Cash Flow from Operations (TTM) | 1.13 kCr |
| Cash Flow from Financing (TTM) | 677.77 Cr |
| Cash & Equivalents | 1.13 kCr |
| Free Cash Flow (TTM) | -596.62 Cr |
| Free Cash Flow/Share (TTM) | -82.62 |
Balance Sheet | |
|---|---|
| Total Assets | 19.44 kCr |
| Total Liabilities | 12.04 kCr |
| Shareholder Equity | 7.4 kCr |
| Current Assets | 8.46 kCr |
| Current Liabilities | 6.46 kCr |
| Net PPE | 8.17 kCr |
| Inventory | 2.54 kCr |
| Goodwill | 0.00 |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.42 |
| Debt/Equity | 1.1 |
| Interest Coverage | -0.43 |
| Interest/Cashflow Ops | 2.54 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 3 |
| Dividend Yield | 0.56% |
| Shares Dilution (1Y) | 0.00% |
| Shares Dilution (3Y) | 0.00% |
Summary of Latest Earnings Report from Uflex
Summary of Uflex's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Last updated:
In the Q1 FY26 earnings call, UFlex Limited's management provided an optimistic outlook. They reported a revenue increase of 6.5% year-on-year, reaching Rs.3,922 crores, driven by a 7.9% sales volume increase. Key growth was noted in the packaging segment, particularly BOPP films, which grew by 6.8%. The PET resin production attained 97% capacity utilization in India and 75% in Egypt.
Management highlighted the positive impact of recent industry dynamics, following an incident that affected a major player in the packaging film industry. This event improved demand-supply balance, likely leading to better margins in upcoming quarters. They anticipate an increase in revenues from new expansions, expecting an additional Rs.3,000 crores at 85% capacity utilization and an EBITDA of Rs.600 crores from new projects, including Aseptic Packaging and recycling facilities.
They acknowledged challenges, particularly from U.S. tariffs, which could affect margins but are hopeful about potential tariff resolutions. The company's capital expenditures of approximately Rs.2,000 crores include projects in India and Egypt, with Rs.1,100 crores already spent.
Management expressed confidence that as projects come online, margins and overall profitability would improve, despite a slight dip in EBITDA margin from 12.7% to 12%. The guidance for the fiscal year includes a revenue growth target of around 10%, driven by pricing and volume adjustments in response to market conditions, particularly in light of supply chain adjustments following recent incidents. Overall, UFlex is positioned to capitalize on emerging opportunities in the flexible packaging market.
Last updated:
Major Questions and Answers from the Q&A Section
1. Question from Chirag Singhal: Asepto expansion has been delayed; can you explain the challenges faced and any expected further delays?
Answer: We are not expecting further delays beyond a slight push, aiming for completion by December 2024 or January. Even if it takes longer, the impact on revenue will not be substantial since the peak demand season is from January to August. Thus, this delay won't hinder our sales significantly.
2. Question from Chirag Singhal: What is your guidance for total Asepto volumes in FY26?
Answer: We're now targeting around 8.5 to 9 billion packs for FY26, having achieved approximately 2.3 billion packs in Q1. This is a slight reduction from our earlier guidance of 10 billion.
3. Question from Chirag Singhal: Why has capacity utilization dropped in regions like Nigeria and Poland?
Answer: Nigeria was hit by increased tariffs from the U.S., causing demand issues. Poland's performance was affected by rising exports from India. However, we expect this to improve as dynamics shift post-June.
4. Question from Aman Kumar: Do you expect better margins in Mexico and Hungary following the incident in India?
Answer: Yes, following the reduction in exports from India due to the incident, we anticipate improved margins in Europe because of decreased supply and potential pricing power.
5. Question from Aman Kumar: What is the outlook for the Flexible Packaging business?
Answer: Volume in the Flexible Packaging segment grew by 7.4% YoY with improved margins. We anticipate sustained growth, particularly influenced by government policies supporting the FMCG sector.
6. Question from Saket Kapoor: What is the estimated revenue contribution from your CPP plant in Mexico?
Answer: The CPP plant is expected to ramp up in Q1 and Q2. While I cannot provide precise figures now, we should see significant contributions once fully operational, especially in FY27.
7. Question from Saket Kapoor: What is the estimated total CAPEX and potential top-line revenue from your new projects?
Answer: Our total planned CAPEX is around Rs.2,000 crores, with revenue potential at approximately Rs.3,000 crores at peak utilization. We anticipate EBITDA of about Rs.600 crores from these projects.
8. Question from Saket Kapoor: Given the current debt, what is the expected net debt-to-EBITDA ratio going forward?
Answer: While our current ratio is about 3.90, we expect it to rise to 4.1. However, as new projects generate additional EBITDA, we aim to reduce this to below 3.0 in the coming financial year.
9. Question from Saket Kapoor: What steps are being taken to control rising costs in employee compensation and utilities?
Answer: Our fixed and semi-fixed costs are reviewed regularly. We can't drastically reduce them in response to lower revenues, but we are optimizing operations to manage efficiency better.
These captured responses provide a detailed view of the company's current operations and future outlook based on the Q&A session during the earnings call.
Revenue Breakdown
Analysis of Uflex's financial performance, highlighting revenue trends, growth patterns, and key metrics through quarterly analysis.
Last Updated: Mar 31, 2025
| Description | Share | Value |
|---|---|---|
| Flexible Packaging Activities | 96.1% | 3.7 kCr |
| Engineering Activities | 3.9% | 150.5 Cr |
| Total | 3.9 kCr |
Share Holdings
Understand Uflex ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
Holding Pattern
Share Holding Details
| Shareholder Name | Holding % |
|---|---|
| Vistra Itcl (india) Limited | 13.57% |
| Flex International Pvt Ltd | 13.3% |
| Anshika Investments Pvt Ltd | 7.99% |
| Kebale Trading Limited | 7.57% |
| A.R.Leasing Pvt Ltd | 6.92% |
| Apoorva Extrusion Pvt Ltd | 5.99% |
| Anshika Consultants Pvt Ltd | 5.23% |
| Keswani Haresh | 4.4% |
| Black Rhino Holdings Limited | 3.6% |
| Ricky Ishwardas Kirpalani | 3.49% |
| First Water Fund | 2.36% |
| Ashok Kumar Chaturvedi HUF (Ashok Kumar Chaturvedi) | 2.35% |
| Ritesh Mukesh Punjabi | 1.9% |
| Anant Overseas Pvt Ltd | 1.38% |
| Ashok Chaturvedi | 0.7% |
| A.L. Consultants Private Limited | 0.49% |
| Rashmi Chaturvedi | 0.17% |
| Magic Consultants Private Limited | 0.06% |
| Foreign Institution Investor | 0.03% |
| Apoorvshree Chaturvedi | 0% |
Overall Distribution
Distribution across major stakeholders
Ownership Distribution
Distribution across major institutional holders
Is Uflex Better than it's peers?
Detailed comparison of Uflex against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| TCPLPACK | TCPL Packaging | 2.97 kCr | 1.81 kCr | -2.30% | -4.50% | 22.25 | 1.64 | - | - |
| HUHTAMAKI | HUHTAMAKI INDIA | 1.75 kCr | 2.53 kCr | +7.50% | -40.40% | 23.51 | 0.69 | - | - |
Sector Comparison: UFLEX vs Industrial Products
Comprehensive comparison against sector averages
Comparative Metrics
UFLEX metrics compared to Industrial
| Category | UFLEX | Industrial |
|---|---|---|
| PE | 13.09 | 19.33 |
| PS | 0.25 | 0.80 |
| Growth | 10.8 % | 11.3 % |
Performance Comparison
UFLEX vs Industrial (2021 - 2025)
- 1. UFLEX is among the Top 3 Packaging companies by market cap.
- 2. The company holds a market share of 27.5% in Packaging.
- 3. The company is growing at an average growth rate of other Packaging companies.
Income Statement for Uflex
Balance Sheet for Uflex
Cash Flow for Uflex
What does Uflex Limited do?
Uflex Limited manufactures and sells flexible packaging materials and solutions in India, the United States, Canada, Egypt, Europe, and internationally. The company operates through Flexible Packaging Activities, Engineering Activities, and Others. Its Packaging Films division offers bi-axially oriented polyethylene terephthalate (BOPET) films; bi-axially oriented polypropylene (BOPP) films; cast polypropylene (CPP) films; metallized films; special effects films; and Alox coated films. The company's Chemical division offers primers, water-based flexo and gravure inks, radiation-curable inks, solvent based inks, topcoats, heat seal coatings, barrier coatings for PE replacements, water-based blister coatings, Energy curable coatings, UV coatings, solvent-based matt and gloss coatings, UV LED coatings, and other products, as well as solvent-based, solvent-free and water-based laminating adhesives. Its Aseptic Liquid Packaging division offers packaging materials, filling machines, and flexible packaging solutions. The company's Holography division provides holograms, holographic films, textile value addition products, hot stamping foils, holographic metalized papers and board transfers, and labeling solutions. Its Flexible Packaging division provides flexible laminates, pre-formed pouches, flexo printed rolls and bags, laminated woven poly propylene bags, electron beam and cast n cure packaging products, packing products for pharmaceuticals, flexitubes, hygiene films, modified atmosphere packaging products, shower proof bags, and injection moulding products, as well as N-95 masks. The company's Printing Cylinders division offers gravure cylinders, flexo plates, and flexo printing sleeves. Its Engineering division provides packaging and converting machines, as well as specialty products. It exports its products to the United States, Europe, the Asia Pacific, the Middle East, Africa, and internationally. Uflex Limited was founded in 1983 and is based in Noida, India.